InMed Pharmaceuticals Inc
Research InMed Pharmaceuticals Inc (INM) on Bullrun: market cap USD 4.77M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINM
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 4.77M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 2.97M
- Free cash flow-USD 1.70M
Valuation Snapshot
latest market cap is USD 4.77M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 4.94M | -USD 8.16M | -USD 7.42M | 34.5% | -8.36 | USD 10.74M | USD 531.95K | USD 13.43M |
| FY2024 | USD 4.60M | -USD 7.68M | -USD 7.00M | 23.9% | -20.14 | USD 6.57M | USD 948.96K | USD 9.21M |
| FY2023 | USD 4.14M | -USD 7.95M | -USD 7.44M | 33.9% | -3.25 | USD 8.91M | USD 1.17M | USD 12.09M |
| FY2022 | USD 1.37M | -USD 18.60M | -USD 15.62M | 39.8% | -33.17 | USD 6.18M | USD 793.77K | USD 9.08M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 4.77M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.97M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.43M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.75M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.21M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 18.54M | n/a | n/a | n/a |
About InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is InMed Pharmaceuticals Inc's market cap?
InMed Pharmaceuticals Inc's market capitalization is USD 4.77M.
What does InMed Pharmaceuticals Inc do?
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.